RESEARCHER PROFILE
Jason Rogers (Filmed April 2024)
Postdoctoral Fellow
Menzies Institute for Medical Research,
University of Tasmania
Jason Rogers is a Tasmanian physiotherapist clinician-researcher with a longstanding interest in improving musculoskeletal foot and ankle conditions. He completed his PhD at the Menzies Institute for Medical Research at the University of Tasmania in 2022 investigating the clinical and imaging factors associated with a common foot complaint known as chronic plantar heel pain.
Chronic plantar heel pain, historically known as plantar fasciitis, is common and commonly recalcitrant, yet the optimal treatment for this condition is not clear. The focus of Jason’s postgraduate research is on improving treatment pathways for chronic plantar heel pain. In particular his research has identified that there are many different sub-groups of plantar heel pain that may warrant specific and individualised treatment approaches. For example his research found that up to half of people with this condition have a type of bone bruise or stress response in the heel known as a ‘bone marrow lesion’ (BML). His BALSA trial will test the effectiveness of targeting these lesions with a bone-sensitive treatment known as shockwave therapy, comparing pain and BML size outcomes against a sham shockwave control group.
As well as improving treatment outcomes for this specific and sizeable sub-group of heel pain sufferers, this research will help inform the future of targeted care treatment approaches for plantar heel pain.
You Might also like
-
Superslayer taking on antibiotic-resistant bacteria
Dr Katharina Richter is a visionary leader in MedTech, acclaimed for innovation and gender diversity. With over 40 awards to her name, including MIT Innovator Under 35 Asia-Pacific, and Prime Minister’s Prize for New Innovator finalist, she has shattered barriers as an entrepreneur, scientist, and ‘superbug slayer.’ Katharina’s groundbreaking work in combating antibiotic-resistant bacteria has resulted in 6 innovative treatments, 3 of which are patented, offering hope against deadly infections.
-
Behavioural science in cancer screening, control and communication
Dr Dodd has an established international reputation as a behavioural scientist in cancer control and communication. Since completing her PhD in 2016, Dr Dodd has been awarded a three-year University of Sydney Postdoctoral Research Fellowship (2018-2021) and a three-year Research Fellowship at The Daffodil Centre (current). Dr Dodd is the co-chair of the ‘Strengthening and optimising approaches to cancer prevention, screening, and early detection’ hub at The Daffodil Centre (with more than 130 staff and students).
-
Dr Nischal Sahai
RESEARCH IN DEVICE TRIALS, VACCINE STUDIES, ORAL MEDICATIONS, INJECTABLES & INFUSIONS.
@ CLINICAL TRIAL CENTRE, UNIVERSITY OF THE SUNSHINE COAST
QUEENSLAND, AUSTRALIA